AC Immune SA Sustainability Reports
AC Immune SA is a clinical-stage biopharmaceutical company focusing on precision medicine for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop therapeutics and diagnostics targeting protein misfolding.
Sector: Manufacturing
Country: Switzerland
Exchange: Nasdaq
LEI: 967600VLQ0ZC2HSOG765
FIGI: BBG00D0RHJ65
4 reports from 2017 to 2024
